Edgewise Therapeutics (EWTX) Other Working Capital Changes (2022 - 2026)
Edgewise Therapeutics (EWTX) posted Other Working Capital Changes of -$196000.0 for Q1 2026, down 1.55% sequentially from -$193000.0 in Q4 2025, and down 9.5% YoY from -$216567.9 in Q1 2025.
Edgewise Therapeutics (EWTX) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Edgewise Therapeutics has reported Other Working Capital Changes for 5 years, with the latest figure at -$196000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 9.5% year-over-year to -$196000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$765000.0 (down 225.53% YoY) and the FY2025 annual result came in at -$748000.0, down 240.0% from the prior year.
- Other Working Capital Changes slipped to -$196000.0 in Q1 2026 per EWTX's latest filing, from -$193000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.7 million in Q4 2025 and troughed at -$3.0 million in Q1 2026.
- A 5-year average of $390058.8 and a median of $359000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes soared 383.33% in 2023, then plunged 241.38% in 2024.
- Over 5 years, Other Working Capital Changes stood at $1.8 million in 2022, then slumped by 106.58% to -$117000.0 in 2023, then jumped by 351.28% to $294000.0 in 2024, then sank by 165.65% to -$193000.0 in 2025, then fell by 1.55% to -$196000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$196000.0, -$193000.0, and -$189000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Edgewise Therapeutics | 4.76 Bn | 4.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -203,000.00 |
| Jun 30, 2026 | -203,000.00 |
| Jun 30, 2026 | -203,000.00 |
| Mar 31, 2026 | -196,000.00 |
| Mar 31, 2026 | -196,000.00 |
| Mar 31, 2026 | -196,000.00 |
| Dec 31, 2025 | -193,000.00 |
| Dec 31, 2025 | -193,000.00 |
| Dec 31, 2025 | -193,000.00 |
| Sep 30, 2025 | -189,000.00 |
| Sep 30, 2025 | -189,000.00 |
| Sep 30, 2025 | -189,000.00 |
| Jun 30, 2025 | -187,000.00 |
| Jun 30, 2025 | -187,000.00 |
| Jun 30, 2025 | -187,000.00 |
| Mar 31, 2025 | -179,000.00 |
| Mar 31, 2025 | -179,000.00 |
| Mar 31, 2025 | -179,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Dec 31, 2024 | 294,000.00 |